InterVest is a corporate investor founded in 1987 in the United States. With its main office in Kirkland, the company typically invests in funding rounds ranging from $10 to $50 million. InterVest has a higher rate of exit commitments compared to other companies, and its most active year was in 2019. The fund participates in 2-6 investment rounds annually, usually with 6-7 participants. While InterVest is a significant investor, startups are also often financed by Solidus Investment, SBI Investment, and Mirae Asset Venture Investment. The fund has no specific preference for the number of founders in portfolio startups, but startups with 4 or 5+ founders have a lower chance of receiving investment. Despite being established in the United States, InterVest frequently invests in South Korea. The fund primarily focuses on investing in the biotechnology and pharmaceutical industries, and it typically invests in startups that are 2-3 years old. Some notable portfolio startups of InterVest include ImmunoMet Therapeutics, Aerodyne Group, and Neuraly.